Switch theme
Sign up to access all valuation multiples
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
2008
516
LTM Revenue $176M
LTM EBITDA -$2.8M
$503M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
SI-BONE has a last 12-month revenue of $176M and a last 12-month EBITDA of -$2.8M.
In the most recent fiscal year, SI-BONE achieved revenue of $167M and an EBITDA of -$23.1M.
SI-BONE expects next 12-month revenue of XXX and NTM EBITDA of XXX
See SI-BONE valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $139M | $167M | XXX | XXX | XXX |
| Gross Profit | $90.7M | $109M | XXX | XXX | XXX |
| Gross Margin | 65% | 65% | XXX | XXX | XXX |
| EBITDA | -$34.4M | -$23.1M | XXX | XXX | XXX |
| EBITDA Margin | -25% | -14% | XXX | XXX | XXX |
| Net Profit | -$61.3M | -$43.3M | XXX | XXX | XXX |
| Net Margin | -44% | -26% | XXX | XXX | XXX |
| Net Debt | $14.5M | $2.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 29, 2025, SI-BONE's stock price is $14.
SI-BONE has current market cap of $615M, and EV of $503M.
See SI-BONE trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $503M | $615M | XXX | XXX | XXX | XXX | $-0.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 29, 2025, SI-BONE has market cap of $615M and EV of $503M.
SI-BONE's trades at 2.9x LTM EV/Revenue multiple, and -176.5x LTM EBITDA.
Analysts estimate SI-BONE's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for SI-BONE and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $503M | XXX | XXX | XXX |
| EV/Revenue | 3.0x | XXX | XXX | XXX |
| EV/EBITDA | -21.8x | XXX | XXX | XXX |
| P/E | -19.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -21.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSI-BONE's NTM/LTM revenue growth is 16%
SI-BONE's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, SI-BONE's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate SI-BONE's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for SI-BONE and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 20% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -14% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -33% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 2% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 70% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 20% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 100% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SI-BONE acquired XXX companies to date.
Last acquisition by SI-BONE was XXXXXXXX, XXXXX XXXXX XXXXXX . SI-BONE acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was SI-BONE founded? | SI-BONE was founded in 2008. |
| Where is SI-BONE headquartered? | SI-BONE is headquartered in United States of America. |
| How many employees does SI-BONE have? | As of today, SI-BONE has 516 employees. |
| Who is the CEO of SI-BONE? | SI-BONE's CEO is Ms. Laura A. Francis. |
| Is SI-BONE publicy listed? | Yes, SI-BONE is a public company listed on NAS. |
| What is the stock symbol of SI-BONE? | SI-BONE trades under SIBN ticker. |
| When did SI-BONE go public? | SI-BONE went public in 2018. |
| Who are competitors of SI-BONE? | Similar companies to SI-BONE include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of SI-BONE? | SI-BONE's current market cap is $615M |
| What is the current revenue of SI-BONE? | SI-BONE's last 12-month revenue is $176M. |
| What is the current EBITDA of SI-BONE? | SI-BONE's last 12-month EBITDA is -$2.8M. |
| What is the current EV/Revenue multiple of SI-BONE? | Current revenue multiple of SI-BONE is 2.9x. |
| What is the current EV/EBITDA multiple of SI-BONE? | Current EBITDA multiple of SI-BONE is -176.5x. |
| What is the current revenue growth of SI-BONE? | SI-BONE revenue growth between 2023 and 2024 was 20%. |
| Is SI-BONE profitable? | Yes, SI-BONE is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
